World's First Patient Receives Immune Cell Therapy for Cancer Treatment
A new type of cancer treatment has been tested in a patient for the first time anywhere in the world. Doctors gave 58-year-old Tracy Tomlinson, who has advanced ovarian cancer, an experimental immune cell therapy called ZI-MA4-1 as part of a Phase 1 clinical trial at The Christie NHS Foundation Trust in Manchester, UK. Tracy joined the study after her cancer returned despite several surgeries and chemotherapy treatments. Unlike chemotherapy, which kills both cancer cells and some healthy cells, ZI-MA4-1 uses specially modified Natural Killer (NK) immune cells to find and destroy cancer cells carrying a protein called MAGE-A4, while causing less harm to healthy tissues. Researchers are currently studying whether the treatment is safe and what dose works best.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.